CHR. HANSEN (UK) LIMITED
Get an alert when CHR. HANSEN (UK) LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-03-30 (in 10mo)
Last made up 2026-03-16
Watchouts
None on the register
Cash
—
Latest balance sheet
Net assets
£3M
Equity attributable
Employees
21
Average over period
Profit before tax
£794K
Period ending 2024-12-31
Net assets
4-year trend · vs Consumer Staples median
Accounts
4-year trend · latest reflected 2024-12-31
| Metric | Trend | 2021-08-31 | 2022-08-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Turnover | — | — | £30,043,000 | £21,528,000 | |
| Operating profit | — | — | £1,505,000 | £838,000 | |
| Profit before tax | — | — | £1,447,000 | £794,000 | |
| Net profit | — | — | £1,069,000 | £591,000 | |
| Cash | — | — | — | — | |
| Total assets less current liabilities | — | — | — | — | |
| Net assets | — | — | £2,905,000 | £3,496,000 | |
| Equity | £7,203,000 | £7,336,000 | £2,905,000 | £3,496,000 | |
| Average employees | — | — | 20 | 21 | |
| Wages | — | — | £1,810,000 | £1,568,000 | |
| Directors' remuneration | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2021-08-31 | 2022-08-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Operating margin | — | — | 5.0% | 3.9% | |
| Net margin | — | — | 3.6% | 2.7% | |
| Gearing (liabilities / total assets) | — | — | 56.0% | 49.1% | |
| Current ratio | — | — | 2.20x | 2.75x | |
| Interest cover | — | — | 18.58x | 19.05x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- CHR. HANSEN (UK) LIMITED 1995-01-01 → present
- CHR.HANSEN'S LABORATORY,LIMITED 1916-12-06 → 1995-01-01
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- UHY Ross Brooke
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a going concern basis. The Company has confirmed that they are able to continue in operation for at least twelve months from the date of signing the financial statements.”
Significant events
- “The previously announced merger between Chr Hansen and Novozymes groups completed on 29 January 2024 and pursuant to that the shares in the company were transferred to Novozymes A/S and Chr. Hansen (UK) Ltd remained a wholly owned subsidiary of Novozymes for the remainder of the year.”
- “As a result of the merger between Novozymes and Chr. Hansen on 31 January 2024, Chr Hansen (UK) Limited were required to divest their Lactase division. This was sold to Kerry Ingredients UK Ltd on 30 April 2024.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 22 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JOHNSON, Ian Nicholas | Secretary | 1996-03-25 | — | British |
| HOLMSGAARD, Eva | Director | 2024-07-01 | Jun 1968 | Danish |
| WILLEMANN, Katrine | Director | 2024-01-31 | Aug 1974 | Danish |
Show 22 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BROWN, David John | Secretary | — | 1993-07-22 |
| COWAN, Brian Campbell | Secretary | 1995-09-08 | 1996-03-25 |
| COWAN, Brian Campbell | Secretary | 1993-07-22 | 1994-04-05 |
| CRONIN, Carol | Secretary | 1994-04-05 | 1995-09-08 |
| BUGEL, Winnie Hojvang | Director | 2006-05-04 | 2024-07-01 |
| COWAN, Brian Campbell | Director | — | 2004-08-31 |
| DE JONG, Cornelis | Director | 2013-04-01 | 2018-06-01 |
| DINESEN, Vagn Aage | Director | — | 1996-10-04 |
| FREDERIKSEN, Lars Vinge, Ceo | Director | 2006-05-04 | 2013-04-01 |
| FREDERIKSEN, Lars Vinge, Ceo | Director | 1996-10-04 | 2001-10-26 |
| GRABER, Mauricio | Director | 2018-06-01 | 2024-01-31 |
| HANSEN, Poul | Director | — | 2001-10-26 |
| HUNT, Ernest Frederick | Director | — | 1992-10-12 |
| HURLEY, Mark | Director | 2004-08-31 | 2026-02-25 |
| JAKOBSEN, Henning Ingwar | Director | 2006-05-04 | 2011-09-30 |
| JOHNSON, Ian Nicholas | Director | 2005-07-27 | 2006-05-04 |
| JOHNSTON, Mark | Director | 1996-10-04 | 2000-10-06 |
| LONNING, Soeren Westh | Director | 2015-08-01 | 2020-10-30 |
| MICHELSEN, John Michael Goth | Director | — | 1993-10-11 |
| MORTENSEN, Lise Skaarup | Director | 2020-10-30 | 2024-01-31 |
| PEDERSEN, Klaus | Director | 2011-10-01 | 2015-08-01 |
| PETERSEN, Niels Torben Lerche | Director | 2001-10-26 | 2006-05-04 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Novozymes A/S | Corporate entity | Shares 75–100% | 2024-01-31 | Active |
| Chr Hansen Holding A/S | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-06-30 | Ceased 2024-01-31 |
Filing timeline
Last 20 of 156 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-02-25 | TM01 | officers | Termination director company with name termination date | |
| 2025-05-29 | AA | accounts | Accounts with accounts type full | |
| 2025-03-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-20 | AP01 | officers | Appoint person director company with name date | |
| 2024-08-20 | TM01 | officers | Termination director company with name termination date | |
| 2024-06-18 | AA | accounts | Accounts with accounts type full | |
| 2024-03-19 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-02-12 | CH01 | officers | Change person director company with change date | |
| 2024-02-12 | AP01 | officers | Appoint person director company with name date | |
| 2024-02-12 | TM01 | officers | Termination director company with name termination date | |
| 2024-02-12 | TM01 | officers | Termination director company with name termination date | |
| 2024-02-12 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2024-02-12 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2023-04-17 | AA01 | accounts | Change account reference date company current extended | |
| 2023-03-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-01-25 | AA | accounts | Accounts with accounts type full | |
| 2022-03-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-02-02 | AA | accounts | Accounts with accounts type full | |
| 2021-03-18 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.